NEW MEMBER | GUTY

Latest Posts

Pherecydes Pharma strengthens its intellectual property with the first patent granted in Israel

30 November 2021

Pherecydes Pharma, a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces that... View Article

OSE Immunotherapeutics provides an update on the first positive results and clinical development of CoVepiT, its multi-target T-cell anti-COVID vaccine

New clinical data confirm the good tolerance of CoVepiT and a very good level of T cell response in healthy... View Article

Valneva signs purchase agreement with European Commission for its inactivated COVID-19 vaccine VLA2001

26 November 2021

Valneva, a specialty vaccine company, today announced that it has signed an Advance Purchase Agreement (APA) with the European Commission... View Article

« Previous 1 … 35 36 37 38 39 … 160 Next »